## Abstract Hybrid cells with a subtetraploid mouse chromosome complement were produced by fusion of three types of human tumour cells with primary mouse embryo cells. The most frequently present presumptive human chromosome was 21. Numerous chromosome rearrangements were present. Some hybrid cells
Construction of viable mouse-human hybrid cells by nuclear transplantation
✍ Scribed by Margaret J. Hightower; Joseph J. Lucas
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 986 KB
- Volume
- 105
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Viable interspecies cytoplasmic‐nuclear hybrid cells were constructed by fusion of karyoplasts prepared from the highly tumorigenic A9 mouse fibroblast cell line and cytoplasts prepared from the Detroit 532 normal human diploid cell strain. The identity of the hybrid cells was ascertained using a variety of morphological, immunological, and genetic criteria, including: nuclear pattern of staining with the fluorochrome Hoechst 33258, appearance of the actin‐myosin containing cytoskeleton, presence of fibronectin, and resistance to azaguanine and diphtheria toxin. About 90% of the hybrid cells were viable, that is, capable of division. Changes in the morphology of the hybrid cells, apparently nuclear directed, were observed before cell division occurred. Using the techniques described here, large numbers of interspecies hybrid cells suitable for many types of biochemical analyses can be routinely produced.
📜 SIMILAR VOLUMES
A method of producing human monoclonal antibody by combining somatic cell hybridization technology with the capability of Epstein-Barr virus (EBV) to transform human B lymphocytes is described. Peripheral blood lymphocytes from a donor with positive tuberculin skin test reaction were transformed by
## Abstract Four independently derived hybrids between the mouse fibroblast line A9 and the human, Burkitt‐lymphoma‐derived lymphoblastoid cell line Daudi were studied for the presence of the Epstein‐Barr virus (EBV) genome, the EBV‐determined nuclear antigen (EBNA), other EBV‐associated antigens,